Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
= 0%; 95% CI, -1.12 to -0.33; P = 0.0003), with very low certainty of evidence. In addition, probiotic intake markedly improved insulin resistance and inflammatory and oxidative stress markers. Preclinical studies have shown that probiotic consumption reduces the incidence and severity of MS, delays MS progression (15 studies), and improves motor impairment (3 studies) with favorable alterations of immune and inflammatory markers (20 studies) and intestinal microbiome compositions (4 studies) in MS. These results indicated that probiotics may have beneficial effects on the prevention and treatment of multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, modulation of the microbiota-gut-brain axis using probiotics could be a promising complementary approach to traditional methods to prevent or counteract these disorders, including PD, as widely reported in literature [315,317,318,319,320].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [317]
Citations
Cites
2 retracted
Kouchaki, E., Tamtaji, O. R., Salami, M., Bahmani, F., Daneshvar Kakhaki, R., Akbari, E., Tajabadi-Ebrahimi, M., Jafari, P., & Asemi, Z. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.08.015 · Cited by 317
RetractedTamtaji, O. R., Kouchaki, E., Salami, M., Aghadavod, E., Akbari, E., Tajabadi-Ebrahimi, M., & Asemi, Z. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1347074 · Cited by 116
RetractedThe Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
SYRCLE’s risk of bias tool for animal studies
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-43 · Cited by 4,415
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
The prevalence of MS in the United States: A population-based estimate using health claims data
Wallin, M. T., Culpepper, W. J., Campbell, J. D., Nelson, L. M., Langer-Gould, A., Marrie, R. A., Cutter, G. R., Kaye, W. E., Wagner, L., Tremlett, H., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007035 · Cited by 1,098
The gut microbiota at the intersection of diet and human health
Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049
Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O. R., Hamidi, G. A., & Salami, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00256 · Cited by 946
Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
Benedict, R. H. B., Amato, M. P., DeLuca, J., & Geurts, J. J. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30277-5 · Cited by 764
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
Duscha, A., Gisevius, B., Hirschberg, S., Yissachar, N., Stangl, G. I., Dawin, E., Bader, V., Haase, S., Kaisler, J., David, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.035 · Cited by 644
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
Liu, R. T., Walsh, R. F. L., & Sheehan, A. E. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.023 · Cited by 564
Sex and gender issues in multiple sclerosis
Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613488434 · Cited by 529
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Host–microbiota interactions in immune-mediated diseases
Ruff, W. E., Greiling, T. M., & Kriegel, M. A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0367-2 · Cited by 487
Murphy, Á. C., Lalor, S. J., Lynch, M. A., & Mills, K. H. G. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.01.014 · Cited by 465
Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B., & Weström, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009009 · Cited by 449
Brinkmann, V. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00451.x · Cited by 438
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Tamtaji, O. R., Heidari-soureshjani, R., Mirhosseini, N., Kouchaki, E., Bahmani, F., Aghadavod, E., Tajabadi-Ebrahimi, M., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.034 · Cited by 398
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
Rojas, O. L., Pröbstel, A.-K., Porfilio, E. A., Wang, A. A., Charabati, M., Sun, T., Lee, D. S. W., Galicia, G., Ramaglia, V., Ward, L. A., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.035 · Cited by 382
KAJANDER, K., MYLLYLUOMA, E., RAJILIĆ‐STOJANOVIĆ, M., KYRÖNPALO, S., RASMUSSEN, M., JÄRVENPÄÄ, S., ZOETENDAL, E. G., DE VOS, W. M., VAPAATALO, H., & KORPELA, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03542.x · Cited by 367
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001443 · Cited by 367
Karussis, D. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.022 · Cited by 366
Liu, Y., Chen, K., Li, F., Gu, Z., Liu, Q., He, L., Shao, T., Song, Q., Zhu, F., Zhang, L., et al. (2020) · Hepatology · doi:10.1002/hep.30975 · Cited by 364
Probiotics, prebiotics, synbiotics and insulin sensitivity
Kim, Y. A., Keogh, J. B., & Clifton, P. M. (2018) · Nutrition Research Reviews · doi:10.1017/s095442241700018x · Cited by 335
Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis
Manjaly, Z.-M., Harrison, N. A., Critchley, H. D., Do, C. T., Stefanics, G., Wenderoth, N., Lutterotti, A., Müller, A., & Stephan, K. E. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320050 · Cited by 321
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512450351 · Cited by 294
Gut microorganisms act together to exacerbate inflammation in spinal cords
Miyauchi, E., Kim, S.-W., Suda, W., Kawasumi, M., Onawa, S., Taguchi-Atarashi, N., Morita, H., Taylor, T. D., Hattori, M., & Ohno, H. (2020) · Nature · doi:10.1038/s41586-020-2634-9 · Cited by 268
Chunchai, T., Thunapong, W., Yasom, S., Wanchai, K., Eaimworawuthikul, S., Metzler, G., Lungkaphin, A., Pongchaidecha, A., Sirilun, S., Chaiyasut, C., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1055-2 · Cited by 267
NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora
Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080622 · Cited by 264
A probiotic modulates the microbiome and immunity in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 264
Probiotic helminth administration in relapsing–remitting multiple sclerosis: a phase 1 study
Fleming, J., Isaak, A., Lee, J., Luzzio, C., Carrithers, M., Cook, T., Field, A., Boland, J., & Fabry, Z. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511398054 · Cited by 260
Telesford, K. M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M. A., Begum-Haque, S., Kasper, D. L., & Kasper, L. H. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1056973 · Cited by 252
The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230
Gut microbiota–specific IgA + B cells traffic to the CNS in active multiple sclerosis
Pröbstel, A.-K., Zhou, X., Baumann, R., Wischnewski, S., Kutza, M., Rojas, O. L., Sellrie, K., Bischof, A., Kim, K., Ramesh, A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc7191 · Cited by 228
Kwon, H.-K., Kim, G.-C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.-E., Nam, J. H., & Im, S.-H. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.001 · Cited by 212
Liu, S., Rezende, R. M., Moreira, T. G., Tankou, S. K., Cox, L. M., Wu, M., Song, A., Dhang, F. H., Wei, Z., Costamagna, G., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.008 · Cited by 198
Takewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011703117 · Cited by 188
He, B., Hoang, T. K., Tian, X., Taylor, C. M., Blanchard, E., Luo, M., Bhattacharjee, M. B., Freeborn, J., Park, S., Couturier, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00385 · Cited by 183
Pan, H., Guo, R., Ju, Y., Wang, Q., Zhu, J., Xie, Y., Zheng, Y., Li, T., Liu, Z., Lu, L., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0719-1 · Cited by 176
Koelmel, E., Hughes, A. J., Alschuler, K. N., & Ehde, D. M. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.09.127 · Cited by 158
Investigation of probiotics in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
Salehipour, Z., Haghmorad, D., Sankian, M., Rastin, M., Nosratabadi, R., Dallal, M. M. S., Tabasi, N. S., Khazaee, M., Nasiraie, L. R., & Mahmoudi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.117 · Cited by 147
Ochoa-Repáraz, J., Mielcarz, D. W., Haque-Begum, S., & Kasper, L. H. (2010) · Gut Microbes · doi:10.4161/gmic.1.2.11515 · Cited by 143
Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis
Singer, J. R., Blosser, E. G., Zindl, C. L., Silberger, D. J., Conlan, S., Laufer, V. A., DiToro, D., Deming, C., Kumar, R., Morrow, C. D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0640-y · Cited by 143
Takata, K., Kinoshita, M., Okuno, T., Moriya, M., Kohda, T., Honorat, J. A., Sugimoto, T., Kumanogoh, A., Kayama, H., Takeda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027644 · Cited by 135
Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A., & Docagne, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30165-x · Cited by 127
Shahi, S. K., Freedman, S. N., Murra, A. C., Zarei, K., Sompallae, R., Gibson-Corley, K. N., Karandikar, N. J., Murray, J. A., & Mangalam, A. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00462 · Cited by 126
Morshedi, M., Hashemi, R., Moazzen, S., Sahebkar, A., & Hosseinifard, E.-S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1611-4 · Cited by 124
Wang, Y., Begum-Haque, S., Telesford, K. M., Ochoa-Repáraz, J., Christy, M., Kasper, E. J., Kasper, D. L., Robson, S. C., & Kasper, L. H. (2014) · Gut Microbes · doi:10.4161/gmic.29797 · Cited by 122
Dopkins, N., Nagarkatti, P. S., & Nagarkatti, M. (2018) · Immunology · doi:10.1111/imm.12903 · Cited by 120
Rahimlou, M., Hosseini, S. A., Majdinasab, N., Haghighizadeh, M. H., & Husain, D. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1758887 · Cited by 119
Oliveira, S. R., Simão, A. N. C., Kallaur, A. P., de Almeida, E. R. D., Morimoto, H. K., Lopes, J. M., Dichi, I., Kaimen-Maciel, D. R., & Reiche, E. M. V. (2014) · Nutrition · doi:10.1016/j.nut.2013.08.001 · Cited by 113
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
Reynders, T., Devolder, L., Valles‐Colomer, M., Van Remoortel, A., Joossens, M., De Keyser, J., Nagels, G., D’hooghe, M., & Raes, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51004 · Cited by 113
Wakefield, J. R. H., Bickley, S., & Sani, F. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.02.002 · Cited by 107
Kadowaki, A., Miyake, S., Saga, R., Chiba, A., Mochizuki, H., & Yamamura, T. (2016) · Nature Communications · doi:10.1038/ncomms11639 · Cited by 102
Chen, H., Ma, X., Liu, Y., Ma, L., Chen, Z., Lin, X., Si, L., Ma, X., & Chen, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01662 · Cited by 96
Oliveira, S. R., Kallaur, A. P., Simão, A. N. C., Morimoto, H. K., Lopes, J. M., Panis, C., Petenuci, D. L., da Silva, E., Cecchini, R., Kaimen-Maciel, D. R., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.045 · Cited by 92
The Gut–CNS Axis in Multiple Sclerosis
Kadowaki, A., & Quintana, F. J. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.06.002 · Cited by 92
Salami, M., Kouchaki, E., Asemi, Z., & Tamtaji, O. R. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2018.10.023 · Cited by 88
Hoang, H., Laursen, B., Stenager, E. N., & Stenager, E. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515588973 · Cited by 86
Heshmati, J., Farsi, F., Yosaee, S., Razavi, M., Rezaeinejad, M., Karimie, E., & Sepidarkish, M. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9493-9 · Cited by 86
A unified cell biological perspective on axon–myelin injury
Simons, M., Misgeld, T., & Kerschensteiner, M. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404154 · Cited by 81
A systematic review and meta-analysis of the probiotics and synbiotics effects on oxidative stress
Heshmati, J., Farsi, F., Shokri, F., Rezaeinejad, M., Almasi-Hashiani, A., Vesali, S., & Sepidarkish, M. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.049 · Cited by 73
Filippini, G., Giovane, C. D., Clerico, M., Beiki, O., Mattoscio, M., Piazza, F., Fredrikson, S., Tramacere, I., Scalfari, A., & Salanti, G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012200.pub2 · Cited by 65
Chitrala, K. N., Guan, H., Singh, N. P., Busbee, P. B., Gandy, A. O., Mehrpouya‐Bahrami, P., Ganewatta, M. S., Tang, C., Chatterjee, S., Nagarkatti, P. S., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646792 · Cited by 61
Ruíz-Argüelles, A., Méndez-Huerta, M. A., Lozano, C. D., & Ruiz-Argüelles, G. J. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.08.014 · Cited by 60
Dargahi, N., Matsoukas, J., & Apostolopoulos, V. (2020) · Brain Sciences · doi:10.3390/brainsci10020126 · Cited by 60
Anti-inflammatory effects of dietary vitamin D 3 in patients with multiple sclerosis
Hashemi, R., Morshedi, M., Jafarabadi, M. A., Altafi, D., Hosseini-Asl, S. S., & Arefhosseini, S. R. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000278 · Cited by 52
Consonni, A., Cordiglieri, C., Rinaldi, E., Marolda, R., Ravanelli, I., Guidesi, E., Elli, M., Mantegazza, R., & Baggi, F. (2018) · Oncotarget · doi:10.18632/oncotarget.25170 · Cited by 50
Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice
Yamashita, M., Ukibe, K., Matsubara, Y., Hosoya, T., Sakai, F., Kon, S., Arima, Y., Murakami, M., Nakagawa, H., & Miyazaki, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02596 · Cited by 49
Calvo-Barreiro, L., Eixarch, H., Ponce-Alonso, M., Castillo, M., Lebrón-Galán, R., Mestre, L., Guaza, C., Clemente, D., del Campo, R., Montalban, X., et al. (2020) · Cells · doi:10.3390/cells9040906 · Cited by 48
Kan, Q., Zhang, H.-J., Zhang, Y., Li, X., Xu, Y., Thomé, R., Zhang, M., Liu, N., Chu, Y., Zhang, G., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0333-1 · Cited by 43
Mestre, L., Carrillo-Salinas, F. J., Feliú, A., Mecha, M., Alonso, G., Espejo, C., Calvo‐Barreiro, L., Luque-Garcia, J. L., Estévez, H., Villar, L. M., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1813532 · Cited by 42
Kobayashi, T., Suzuki, T., Kaji, R., Serata, M., Nagata, T., Ando, M., Iizuka, R., Tsujibe, S., Murakami, J., Kiyoshima-Shibata, J., et al. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.617755 · Cited by 40
Kobayashi, T., Kato, I., Nanno, M., Shida, K., Shibuya, K., Matsuoka, Y., & Onoue, M. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903200716 · Cited by 38
Agah, S., Akbari, A., Heshmati, J., Sepidarkish, M., Morvaridzadeh, M., Adibi, P., Mazidi, M., Farsi, F., Ofori‐Asenso, R., Talley, N. J., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103902 · Cited by 38
Abdurasulova, I. N., Matsulevich, A. V., Тарасова, Е. А., Kudryavtsev, I. V., Серебрякова, М. К., Ермоленко, Е. И., Бисага, Г. Н., Клименко, В. М., & Suvorov, A. N. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0018 · Cited by 27
Kan, Q., Zhang, H.-J., Zhang, Y., Li, X., Xu, Y., Thomé, R., Zhang, M., Liu, N., Chu, Y., Zhang, G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0410-0 · Cited by 24
Digehsara, S. G., Name, N., Esfandiari, B., Karim, E., Taheri, S., Ebrahimi, M. T., & Arasteh, J. (2020) · Inflammation · doi:10.1007/s10753-020-01339-1 · Cited by 24
Goudarzvand, M., Koohi, S. R., Khodaii, Z., & Moghadam, S. S. (2016) · PubMed Central · Cited by 20
Samani, S. A., Moloudi, M. R., Ramazanzadeh, R., Abdi, M., Nikkhoo, B., Izadpanah, E., Roshani, D., Abdolahi, A., Esmaili, P. K., & Hassanzadeh, K. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1955.1 · Cited by 13
Immune-directed therapies in MS — efficacy and limitations
Hemmer, B., & Mühlau, M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.2 · Cited by 10
Abdurasulova, I. N., Ермоленко, Е. И., Matsulevich, A. V., Abdurasulova, K. O., Тарасова, Е. А., Kudryavtsev, I. V., Бисага, Г. Н., Suvorov, A. N., & Клименко, В. М. (2017) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-017-0484-1 · Cited by 10
Bajić, S. S., Mihajlović, S., Radojević, D., Popović, D., Đokić, J., Stanisavljević, S., Lazarević, M. N., Miljković, D. M., Ruas‐Madiedo, P., Golić, N., et al. (2019) · Journal of the Serbian Chemical Society · doi:10.2298/jsc190716094s · Cited by 10
Research works printed but not linked: 7
- Correale, 2017, Brain, 140, 527
- Filippini, 2017, Cochrane Database Syst. Rev., 4, Cd012200
- Hashemi, 2018, Neurol.: Genet., 4, e278
- Goudarzvand, 2016, Med. J. Islam. Repub. Iran, 30, 391
- Ebrahim, 2017, Clin. Nutr., 36, 1245, 10.1016/j.clnu.2016.08.015 · DOI · Paper page
- Ochoa-Repáraz, 2010, J. Immunol., 185, 4101, 10.4049/jimmunol.1001443 · DOI · Paper page
- Samani, 2020, Basic Clin. Neurosci., 5, 1396
Cited by
Microbial dysbiosis in the gut drives systemic autoimmune diseases
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906258 · Cited by 185
Bicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“Probiotic studies have shown substantial improvements in multiple animal models of neurodegenerative [231,369–373] and neurodevelopmental diseases [374,375], PD [371,376], and cognitive decline [377] and reductions in symptoms in MS [378], ALS [379], and ASD [380].”
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Snetselaar, L., Cheek, J. J., Fox, S. S., Healy, H. S., Schweizer, M. L., Bao, W., Kamholz, J. A., & Titcomb, T. J. (2022) · Neurology · doi:10.1212/wnl.0000000000201371 · Cited by 94
“Unauthorized reproduction of this article is prohibited. reduce fatigue and improve physical and mental QoL among people with MS.”
BackgroundInfluentialChu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Nutrients · doi:10.3390/nu15071737 · Cited by 79
Metadata
- Authors
- Jiang, J., Chu, C., Wu, C., Wang, C., Zhang, C., Li, T., Zhai, Q., Yu, L., Tian, F., & Chen, W.
- Affiliations
- Jiangnan University (CN)
- Nanjing Forestry University (CN)
- Corresponding author
- Yu, Leilei
- Tian, Fengwei
- ORCID
- Venue
- Food & Function
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 12
- Issue
- 6
- Pages
- 2354-2377
- ISSN
- 2042-6496 (ISSN-L)
- 2042-650X
- OpenAlex
- W3128017280
- Cited by
- 52
- References
- 95
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 9 · 2023: 16 · 2022: 11 · 2021: 3
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Food & Function (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (U1903205, 31772090, 31820103010, 32001665)
- Xinjiang Production and Construction Corps (2018AB010)
- Natural Science Foundation of Jiangsu Province (BK20180603)
- Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, multiple sclerosis, gut microbiota, insulin resistance, oxidative stress, inflammatory markers, motor impairment, disease progression, immunomodulation, preclinical research, randomized controlled trials
- MeSH terms
- Adult, Animals, Female, Humans, Inflammation, Male, Mental Health, Middle Aged, Multiple Sclerosis, Randomized Controlled Trials as Topic, Probiotics, Mice, Rats, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.